We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Abbott E-Mails Could Affect Patent Evergreening Suits

Law360 (January 3, 2007, 12:00 AM EST) -- While efforts by pharmaceutical companies to protect market share have always drawn the scrutiny of regulators, recently uncovered documents from Abbott Laboratories have cast a new light on some of these questionable tactics.

A series of e-mails obtained by the Wall Street Journal has revealed the extent to which some companies go to increase sales of their drugs. In the e-mails, Abbott executives discuss how to protect the company’s blockbuster AIDS drug Kaletra in an increasingly competitive marketplace.

The company considered several options, all of which...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.